Literature DB >> 14194761

ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.

E W MCCHESNEY, E J FROELICH, G Y LESHER, A V CRAIN, D ROSI.   

Abstract

Entities:  

Keywords:  ANTI-INFECTIVE AGENTS; BLOOD; CLINICAL RESEARCH; EXCRETION; FECES; INTESTINAL ABSORPTION; METABOLISM; NALIDIXIC ACID; NAPHTHYRIDINES; URINE

Mesh:

Substances:

Year:  1964        PMID: 14194761     DOI: 10.1016/0041-008x(64)90070-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  26 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  A COMPARATIVE STUDY OF THE LEVELS OF NALIDIXIC ACID IN PLASMA AND URINE AND ITS ANTIBACTERIAL ACTIVITY IN URINARY INFECTIONS OF PARAPLEGICS.

Authors:  N O GIBBON; J G BENSTEAD; G C MISRA
Journal:  Postgrad Med J       Date:  1965-08       Impact factor: 2.401

3.  TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.

Authors:  R M JAMESON
Journal:  Br Med J       Date:  1965-09-11

4.  Nalidixic Acid: microbiological and clinical studies on urinary infections in children.

Authors:  R L Newman; R J Holt; C H Frankcombe
Journal:  Arch Dis Child       Date:  1966-08       Impact factor: 3.791

5.  Distribution of gentamicin in body fluids.

Authors:  G D Chisholm; J S Calnan; P M Waterworth; N D Reis
Journal:  Br Med J       Date:  1968-04-06

6.  Pipemidic acid: absorption, distribution, and excretion.

Authors:  M Shimizu; S Nakamura; Y Takase; N Kurobe
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

7.  The effect of infinitesimal drug dilutions on the pharmacokinetics of nalidixic acid and atenolol.

Authors:  N Ferry; N Bernard; N Pozet; E Gardes; M Bruguier; G Cuisinaud; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 8.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 9.  Modulation of the host flora.

Authors:  R van Furth; H F Guiot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

Review 10.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.